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Abstract. Dialysis in the infant carries a mortality rate of 
16%. Institution of dialysis may be the result of adequate 
nutritional intake, but avoidance of nutritional intake 
should never be seen as a way to prevent dialysis. Increased 
caloric intake, usually via enteral feeding tubes, is needed 
for optimal growth in the infant with end-stage renal dis- 
ease (ESRD) in order to attain adequate nutrition with re- 
sulting good growth. "Renal" formulae may be constituted 
as dilute (as in the polyuric infant) or concentrated (as in 
the anuric infant) to fit the infants needs. Peritoneal dialysis 
(PD) is the usual mode of renal replacement therapy (97%), 
with access via a surgically placed cuffed catheter with 
attention to the placement of the exit site in order to avoid 
fecal or urinary contamination. PD volumes of 30 -40  ml/ 
kg per pass or 800-1,200 ml/m 2 per pass usually result in 
dialysis adequacy. Additional dietary sodium (3-5  mEq/kg 
per day) and protein (3 -4  g/kg per day) are needed, due to 
sodium and protein losses in the dialysate. Protein losses 
are associated with significant infectious morbidity and 
nonresponsiveness to routine immunizations. Hemodialysis 
(HD) can be performed either as single- or dual-needle 
access that have minimal dead space (less then 2 ml) and 
recirculation rate (less then 5%). Attention to extra- 
corporeal blood volume ( <  10% of intravascular volume), 
blood flow rates (3 -5  ml/kg per min), heparinization (ac- 
tivated clotting times), ultrafiltration (ultrafiltration moni- 
tor), and temperature control is imperative during each 
treatment. Because infants' nutrition is mostly fluid, HD 
may be needed 4 - 6  days/week (especially in the oligo- 
anuric infant) to avoid excessive volume overload between 
treatments. At the end of the treatment a slow blood return 
with minimal saline rinse is needed to avoid hemodynamic 
compromise. Infant dialysis, although technically challen- 
ging with a significant morbidity and mortality rate, can be 
safely carried out in the infant with ESRD but requires 
infant-specific equipment and trained personnel. 
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Introduction 
End-stage renal disease (ESRD) requiring dialysis has an 
incidence rate of 6 per 1,000,000 in the pediatric age range 
from 0 to 4 years of age [1]. Although the incidence is quite 
low, the mortality rate in this population on dialysis ap- 
proaches 16% per year or has an estimated mortality rate of 
21% over a 2-year period. This is significantly greater then 
those children over 5 years, with a mortality rate of 3% per 
year. This high mortality rate makes both the care of the 
infant and the prevention of a complication an ongoing 
struggle effecting infant survival. 
The etiologies of ESRD in the specific age group of 
0 - 1  year are limited [2]. These include congenital 
anomalies that are associated with high-output renal failure, 
such as renal dysplasia or hypoplasia, infants with con- 
genital nephrotic syndrome, as well as hemodynamic cau- 
ses, including cortical necrosis, which may be associated 
with anuric renal failure. Understanding the etiology of 
ESRD will help in the management of the child. Dividing 
the infants into polyuric and anuric renal failure is helpful 
in differentiating the variations of either dialysis modality 
that may be necessary in the infant. 
Polyuric renal failure 
Children with high-output renal failure are easier to manage 
either conservatively or on dialysis. These children typi- 
cally have a urine output of 2 to 3 times normal, losing a 
significant amount of free water and sodium. Therefore, 
attention to water as well as sodium replacement in this 
population is important. Due to the fact that these children 
are usually struggling to maintain euvolemia (with the 
ongoing potential risk of hypovolemia), this group usually 
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requires dialysis primarily for urea, phosphorus, and po- 
tassium management, not ultrafiltration requirements. The 
down side of the urine output is that this group has a ten- 
dency to become rapidly dehydrated with an increased 
mortality rate secondary to dehydration. 
This group may be managed "conservatively" without 
renal replacement therapy (RRT) if adequate nutrition and 
volume (including extra salt) are given to the infant. The 
use of enteral feeding tubes has become, in many centers, 
the "norm", making euvolemia maintenance easier to attain 
[3]. Because most infant "renal" formulae are low in so- 
dium, the addition of sodium chloride and/or sodium bi- 
carbonate of 2 - 4  mEq/100 ml of infant formula may be 
necessary to match the urinary sodium losses that occur in 
this population. Analysis of the urinary sodium at the time 
the infant is euvolemic may be helpful in determining the 
amount of sodium the polyuric infant requires. 
Anuric renal failure 
The infant with anuric ESRD is more difficult to care for 
because of the ongoing risk of volume overload. Due to the 
fact that more then 90% of the infant's nutrition is fluid 
based, frequent dialysis may be necessary, more for ultra- 
filtration than urea clearance. The use of concentrated 
formulae (see nutrition) may be needed in this population. 
These patients can not be managed for more then a few 
days without RRT. Nutrition should not be restricted in 
order to avoid dialysis, due to the ongoing catabolic needs 
of the growing infant. 
Dialysis techniques 
Peritoneal dialysis 
Peritoneal dialysis (PD) accounts for more than 95% of the 
mode of dialysis in infants [4]. Although there are no PD 
cyclers that are infant specific, most cyclers have the 
capability of delivering small volumes (50 ml) to the infant. 
Further, infants may be maintained on continuous am- 
bulatory PD with the use of small dialysate bags and scales 
to weigh the amount of dialysate delivered and ultra- 
filtrated. Attention to the dead space of the dialysis tubing 
is important in order to avoid "recirculation" of the dialy- 
sate. 
A typical infant requires somewhere between 800 and 
1,200 ml/m 2 or 30 -40  ml/kg of intraperitoneal volume per 
pass. This should result in adequate dialysis as well as ul- 
trafiltration [5, 6]. A starting intraperitoneal volume of 
10-12 ml/kg per pass and increasing to the previously 
mentioned volumes over a 3- to 4-week period can result in 
adequate dialysis. One of the difficulties with machines at 
this lower volume is that of low drain alarms on return. In 
the anuric infant, this is usually not an issue since the pa- 
tient will usually return more than 100% of the infused 
volume because of the addition of the ultrafiltrate. In the 
polyuric infant it is common, due to these small volumes 
and because of absorption of dialysate, that the low-drain 
alarms are triggered causing additional anxiety to the infant 
and family. Most low-drain alarms are set to alarm if 85% 
of the dialysate is not returned within two-thirds of the 
allotted time. These can be adjusted on the machine. Care 
should be taken, however, to insure that the patient is not 
third spacing extraperitoneally, which may not be clinically 
apparent. 
The standard sodium concentration of peritoneal dialy- 
sate is 132 mEq/1. This results in a net loss of sodium across 
the peritoneum in the majority of infants, usually requiring 
the addition of enteral or peritoneal sodium to mitigate this 
problem [7]. This negative sodium balance may be ex- 
acerbated in the infant with polyuric renal failure due to the 
ongoing urinary sodium loss. It is important in infants on 
PD with ESRD that sodium supplementation be given to 
maintain intravascular integrity. It may be necessary to 
supplement as much as 5 - 1 0  mEq/kg of additional sodium 
in these infants due to the combined losses of sodium in the 
urine and the dialysate. 
The phosphorus and potassium clearance is less pro- 
blematic in this population. Electrolyte normalization can 
be well obtained not only between phosphorus and potas- 
sium restrictive formulae, but also because most of these 
infants have adequate clearance due to increased (as op- 
posed to older children) peritoneal membrane permeability. 
In the polyuric infant the absorbed dialysate will further 
increase urine output thereby increasing phosphorus and 
potassium clearance. Because of this phenomena, after 
some infants are started on PD, transition to a "normal" 
formula may be required for a period of time until further 
(and ongoing) deterioration of native kidney function 
o c c u r s .  
Ultrafiltration requirements in infants on PD will be 
dependent upon the degree of urine output and the amount 
of nutrition necessary for growth. In the polyuric infant, 
little need for ultrafiltration may exist. These infants can be 
well dialyzed on low-glucose-containing dialysate in order 
to avoid extra water losses through the peritoneal mem- 
brane. The ongoing polyuria that occurs in these infants 
places them at additional risk for dehydration if ultra- 
filtration does occur. It is not uncommon that infants with 
polyuria will absorb dialysate. In the face of lack of ul- 
trafiltration, attention to the infant to ensure that third 
spacing of the dialysate is not occurring is important. In the 
anuric infant, ultrafiltration will be dependent upon formula 
intake. Therefore, a higher glucose content may be ne- 
cessary in these infants in order to attain adequate ultra- 
filtration. 
The infant on PD for 12-14 h a day, 7 days a week will 
easily attain adequate growth [8]. Remember that an infant 
may obtain 2 0 -3 0  calories/kg per day of carbohydrate 
calories while on PD. Therefore, it is not surprising that 
many of these infants have weight growth out of proportion 
to height and head circumference growth. 
HemodiaIysis 
Hemodialysis (HD) accounts for only 3% of ESRD thera- 
pies in infants in North America [4]. The obvious diffi- 
culties associated with HD is that of adequate access and 
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appropriate infant-specific HD machines [9, 10]. Recently 
an increased number of accesses have become available 
and many HD machines are adaptable for either infant- 
sized dual-needle or infant-specific single-needle HD [9, 
11]. However despite these advances, HD continues to be 
less used for many reasons. The need for infant-specific 
trained nursing staff and pediatric nephologists to care for 
this high-risk population continues to be a major limitation. 
Attention during a HD treatment is important to avoid 
excessive ultrafiltration [12]. Lrltrafiltration monitors now 
exist in the majority of the newer HD machines in order to 
avoid excessive ultrafiltration. It should be noted that ul- 
trafiltration monitors may have an error rate of + of 
50 ml/h, having as much as 150-200 ml error rate at the 
end of a 3-h treatment. This error rate can be minimized, in 
that once the variation is known the biomedical support 
system from the HD company can tighten the range of 
variation. Many centers utilize an infant scale during HD 
treatment. We have found at the University of  Michigan 
that infant scales become more problematic. Strict attention 
to items placed and removed from these scales must be paid 
throughout the HD treatment in order to avoid a mis- 
calculation of weight. We prefer to have a very strict and 
accurate ultrafiltration monitor for these infants. 
Specific issues of access should include the under- 
standing that they should be low resistance. Resistance of 
blood flow through the access is relative to the internal 
diameter as well as length of the catheter [13]. The best 
access is short and of wide diameter. The newer accesses 
that are specific for infants have become available and can 
be surgically placed in the superior vena cava fight atrial 
junction for short-term "acute" or long-term "chronic" HD. 
At the time of placing the HD lines on the machine, 
attention to the extracorporeal blood volume is important. 
The standard blood volume of the infant is 80 ml/kg. Thus, 
in a 5-kg infant the intravascular blood volume may only be 
400 ml. As a rule, no more than 10% of the blood volume 
should be extracorporeal during the HD treatment, there- 
fore maintaining a circuit of less than 40 ml is important. 
The smallest circuit currently available is 38 ml, which can 
be utilized in an infant as small as 4.5 kg without blood 
priming [9]. Circuits greater than 10% usually require 
blood priming. Blood priming is associated with an in- 
creased risk of antigen exposure, with negative impact 
upon transplantation. Increase in viscosity resistance is 
associated with high hematocrit blood bank blood, as well 
as a high potassium load in blood bank blood [9, 14]. If  
blood bank blood is utilized, diluting the blood with normal 
saline to a hematocrit of 30%-40% will be helpful in terms 
of the viscosity. This will have little to no benefit upon the 
potassium or the antigen expression. If blood bank blood is 
necessary then maneuvers such as using frozen deglycer- 
olized cells or leukopore cells may be helpful in mini- 
mizing the white cell load and subsequent antigen ex- 
posure. 
At the time that the blood lines are placed on the ma- 
chine, attention that occlusion occurs at the site of blood 
pump compression upon the blood tubing is important. If  
the occlusion does not occur then reverse blood flow can 
result. This will result in recirculation and less-efficient 
treatments. If  the occlusion is too tight then hemolysis may 
result. Most HD machines come equipped with an appro- 
priate occluder device that measures the correct amount of 
gap at the size of occlusion. 
Once HO commences, if one maintains less than 10% 
extracorporeal blood volume then either priming with sa- 
line or 5% albumin may be necessary at the beginning of 
the treatment. The standard blood flow rate for HD would 
be between 3 and 5 ml/kg per min with no more than 0.2 ml/ 
kg per min of ultrafiltration to be carried out. Ultrafiltration 
above that will usually result in hemodynamic instability. 
Further, attention to appropriate-sized dialyzers is impor- 
tant. There are a number of newer hollow-fiber dialyzers 
that have small extracorporeal volume but have adequate 
surface area for adequate dialysis as ultrafiltration [9]. 
Many centers utilize "single-needle" access via a 2-mm 
or greater Hickman catheter [15]. This approach requires 
single-needle capability on the HD machine. Although 
potentially less efficient, attention to the arterial and venous 
times will help in maximizing both dialysis as well as ul- 
trafiltration capability respectively. The use of "plate" 
dialyzers is necessary in order to have a compliant system 
necessary in single-needle HD. 
Heparinization during the treatment can be easily 
maintained with a heparin load of 10-20  units/kg bolus 
then 10-20  kg/h. Many institutions utilize a bedside acti- 
vated clotting time (ACT) in order to maintain a controlled 
heparinization [16]. An ACT between 150 and 200 s is 
adequate for a HD treatment. Centers using single-needle 
HD may need to utilize more heparin then stated above, due 
to the hemostasis in the dialyzer that occurs between ar- 
terial and venous components of single-needle HD. 
Attention to the infant at the time of return of the ex- 
tracorporeal blood volume is important. If  one has 10% of 
the blood volume extracorporeal, then an infant could ea- 
sily receive 5 -  8 ml/kg of blood transfusion rapidly. This is 
further exacerbated by the practice of rinsing the system 
once or twice with saline in order to give back all of the 
blood. This may result in replacement to the infant the total 
amount of ultrafiltration that was removed during the 
treatment. These maneuvers could result in hemodynamic 
instabilities as well as cardiac failure or malignant hyper- 
tension. Therefore, slow infusion of the extracorporeal 
blood volume is important. Many institutions utilize an "air 
return" to the patient. This would include a disconnection 
of the arterial port and turning down the blood pump rate 
when returning the blood. The arterial line is subsequently 
a system filled with ail" but the air leak detector is main- 
tained in the active mode during this time in order to avoid 
the air emboli. This has the obvious risk of an air embolus 
to the patient. This has the benefit of avoiding excessive 
saline rinsing of the extracorporeal circuit and giving back 
excessive saline to the infant. Temperature control may be 
difficult in the infant due to a significant extracorporea! 
blood volume and relatively slow blood flow rates. Nor- 
mothermia can be accomplished by increasing the dialysate 
bath temperature during each treatment. 
In the volume-overloaded infant with pulmonary edema, 
attention to the oxygen requirements during the first 
2 0 - 3 0  rain of treatment is imperative. HD dialyzers may 
activate C5a during the initial part of the treatment, re- 
sulting in platelet and white cell aggregation within the 
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vasculature. In the face of an increased arterial-alveolar 
gradient from pulmonary edema, this may be exacerbated 
by the white blood cell and platelet layering along the 
vascular space. Therefore, FIO2 may need to be increased 
initially during the treatment [17]. 
Due to the fact that the majority of nutrition for infants 
is liquid based, as in PD, the number of dialysis treatments 
necessary per week may be partially based upon urine 
output. In the polyuric infant the indication for HD may be 
based more on the needs for dialysis as opposed to ultra- 
filtration. In the anuric infant more dialysis treatments per 
week may be necessary in order to maintain better volume 
control. Although not well studied, most centers will dia- 
lyze infants four to six times per week in order to maximize 
the attempt to maintain some degree of volume constance 
and in order to maximize "clearance" for improved growth. 
Because these children are dialyzed so frequently and due 
to the common use of infant "renal formulae," problems 
such as byperphosphatemia are quite unusual. 
Infectious complications 
Significant protein losses occur in the infant on PD [18]. 
Protein losses resulting in low plasma albumin as well as 
hypogammaglobulinemia may result in an increased risk of 
infection [19]. To date the dialysis database of the North 
American Pediatric Renal Transplant Cooperative Study 
has identified deaths in 15 infants while on dialysis; 14 of 
these deaths occurred on PD while 1 occurred on HD. Since 
at least 95% of infants undergoing RRT in North America 
are on PD, there is a roughly equal percentage of deaths in 
each modality group. Of the 14 deaths on PD, 5 were from 
infectious complications. Whether these patients were hy- 
poalbuminemic or hypogammaglobulinemic is not speci- 
fied in the database, yet one can speculate this may be an 
issue. Centers have shown that not only are these patients 
hypogammaglobulinemic but also have a poor responsive- 
ness to normal infant immunizations [19-21]. Attention to 
these factors may improve the mortality rate in this popu- 
lation. 
In HD protein losses are not similar to PD. It is believed 
that the protein losses and hypogammaglobulinemia that 
occur are directly related to the common protein losses of 
PD. No studies to date have adequately addressed whether 
or not hypogammaglobulinemia is a common finding in 
infants with chronic renal failure (CRF) or ESRD, irre- 
spective of the mode of dialysis. A large number of infants 
with either CRF or ESRD should be investigated. 
Exit site infections occur both in the PD and HD po- 
pulations. Therefore, meticulous attention to side care is 
important to minimize this complication. In adults, HD 
access via a goretex shunt or fistula minimizes the risks of 
site infections when compared with an external access. 
Because infants do not have adequate-sized arteries or 
veins to support a subcutaneous shunt, the external access 
will continue to be associated with the risk of an "exit site 
infection." 
Growth 
Fifty percent of the potential adult height is achieved in the 
first 18-24  months of life [22]. Attention to factors that 
impair growth in the infant with ESRD is important in order 
to minimize growth stunting. Studies to date have sug- 
gested that children on PD grow better than children on HD 
[23]. No studies to date have specifically addressed the 
issue of infants on PD versus HD. Factors that have been 
suggested to enhance growth in the child on PD have in- 
cluded: (1) increased dietary liberalness, (2) improved 
phosphorus control, and (3) most children on PD are dia- 
lyzed at home and are in a more comfortable environment. 
Nutrition 
A number of formulae exist that are quite effective for the 
needs of the infant with ESRD. Ross (Columbus, Ohio, 
USA) makes PM 60/40 (0.67 calorie/ml), Suplena (2 cal- 
ories/ml), and Nepro (2 calories/ml). These can be used 
either full strength as noted or diluted depending on the 
child's urine output. Suplena and Nepro may deliver too 
much magnesium to some infants, therefore monitoring of 
the magnesium may be necessary in some infants. Other 
formulae, such as S-29 (0.67 calories/ml, Wyeth, Phila- 
delphia, Pa., USA) or Amin-Aid (2 calories/ml, American 
McGaw, Irvine, Calif., USA), can also be used for children 
with ESRD. S-29 requires replacement of electrolytes while 
Amin-Aid is depleted in trace elements and therefore both 
require additional additives. 
The use of concentrated formulaes (with their high os- 
molality) in infants with high urine outputs must be avoi- 
ded. This will result in an excessive osmolar load with the 
potential risk of dehydrating the infant who is already at 
risk for the same. Water-soluble vitamins are actively re- 
moved from the infant on dialysis; therefore, specific 
water-soluble vitamins should be replaced in this popula- 
tion. Avoidance of fat-soluble vitamins, including 
vitamin A, should be maintained. It is well documented that 
vitamin A can be retained in children with ESRD, resulting 
in secondary hypervitaminosis [24]. 
Summary 
In summary, infants can be supported on either PD or HD 
as treatment for ESRD. The infant with ESRD on dialysis 
has a significant mortality rate. Inadequate numbers on HD 
are available to address whether the mortality rate is higher 
on one modality than the other. Both modalities have their 
own unique associated risk. The important issue with either 
modality is that experienced nursing staff as well as a pe- 
diatric nephrologist be involved with the care of these pa- 
tients because of their high mortality and risk of compli- 
cations. Further, infant-specific equipment is important for 
use in this population in order to avoid equipment com- 
plications. The mortality rate of infants undergoing trans- 
plantation is less than in infants with ESRD on dialysis [1]. 
Therefore, because of the high mortality rate and the very 
high stress upon families as well as medical care givers, 
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dialysis in infants should only be seen as a bridge to 
transplantation. 
Acknowledgement. I would like to thank Sharon Doyle for her dili- 
gence in the preparation of this manuscript and the nursing staff of the 
HD and PD units of the University of Michigan for their excellent care 
of the children. 
References 
1. United States Renal Data Systems (1993) Annual data report. 
ESRD in children. Chapt VIII, pp 69-81 
2. Najarian JS, Frey DJ, Matas AJ (1990) Renal transplantation in 
infants. Ann Surg 212:353-366 
3. Brewer ED, Holmes S, Tealey J (1986) Initiation and maintenance 
of growth in infants with end stage renal disease (ESRD) managed 
with chronic peritoneal dialysis (CPD) and nasogastric tube (NG) 
feeding. Kidney Int 29:230 
4. Alexander SR, Sullivan EK, Harmon WE, Stablein DM, Tejani A 
(1993) Maintenance dialysis in North American children and 
adolescents: a preliminary report. Kidney Int 44:S104-S109 
5. Salusky IB, Von Lilien T, Anchondo M, Nelson PA, Fine RN 
(1987) Experience with continuous cycling peritoneal dialysis 
during the first year of life. Pediatr Nephrol 1: 172-175 
6. Kohant EC, Whelchel J, Waldo FB, Diethelm AG (1987) Ag- 
gressive therapy of infants with renal failure. Pediatr Nephrol 
1:150-153 
7. Panlson WD, Bock GH, Nelson AR Moxey-Mims MM, Crim LM 
(1989) Hyponatremia in the very young chronic peritoneal dialysis 
patient. Am J Kidney Dis 14:196-199 
8. Warady BA, Kriley M, Lovell H, Farrell SE, Hellerstein S (1988) 
Growth and development of infants with end-stage renal disease 
receiving long-term peritoneal dialysis. J Pediatr 112:714-719 
9. Donckerwolcke R, Bunchman T (1994) Hemodialysis in infants 
and small children. Pediatr Nephrol 8: 103-106 
10. Knight F, Gorynski L, Bentson M, Harmon WE (1993) Hemo- 
dialysis of the infant or small child with chronic renal failure. 
ANNA J 20:315-323 
11. Bunchman TE, Gardner JJ, Kershaw DB, Maxvold NJ (1994) 
Vascular access for hemodialysis or CVVH(D) in infants and 
children. Dial Transplant 23:314-318 
12. Vries PMJM de, Olthof CG, Solf A (1991) Fluid balance during 
hemodialysis and hemofiltration: the effect of dialysate sodium 
and a variable ultrafiltration rate. Nephrol Dial Transplant 
4:257-263 
13. Jenkins RD, Kuhn RJ, Funk JE (1988) Clinical implications of 
catheter variability on neonatal continuous hemofiltration. Trans 
Am Soc Artif Intern Organs 34: 108-111 
14. Alexander SR (1991) Pediatric uses of recombinant human ery- 
thropoietin: the outlook in 1991. Am J Kidney Dis 28:42-53 
15. Mahan JD, Maner SM, Nevins TE (1983) The Hickman catheter. 
A new haemodialysis access device for infants and small children. 
Kidney Int 24:318-319 
16. Geary DF, Gajaria M, Fryer-Keene S, Willumsen J (1991) Low 
dose and heparin-free hemodialysis in children. Pediatr Nephrol 
5:220-224 
I7. Craddock PR, Fehr J, Brigham KL, Kronenberg RD, Jacob HS 
(1987) Complement and leukocyte-mediated pulmonary dysfunc- 
tion in hemodialysis. N Engl J Med 296:769-774 
18. Dulaney JT, Hatch FE Jr (1984) Peritoneal dialysis and loss of 
proteins: a review. Kidney Int 26:253-262 
19. Fivush BA, Case B, May MW, Lederman HM (1989) Hypo- 
gammaglobulinemia in children undergoing continuous ambula- 
tory peritoneal dialysis. Pediatr Nephrol 3: 186-188 
20. Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte 
HJ (1992) Response to measles-mumps-rubella vaccine in children 
on dialysis. Pediatr Nephrol 6: 187-189 
21. Fivush BA, Case B, Warady BA, Lederman H (1993) Defective 
antibody response to Hemophilus influenzae type b immunization 
in children receiving peritoneal dialysis. Pediatr Nephrol 7: 
548-550 
22. Wassner SJ (1994) Conservative management of chronic renal 
insufficiency. In: Holliday MA, Barratt TM, Avner ED (eds) 
Pediatric Nephrology. Williams and Willdns, Baltimore, 
pp 1314-1388 
23. Potter DE, San Luis E, Wipfler JE, Portale AA (1986) Comparison 
of continuous ambulatory peritoneal dialysis and hemodiaiysis in 
children. Kidney Int 19 :Sl l -S14 
24. Yatzidis H, Digenis P, Fountas P (1975) Hypervitaminosis A ac- 
companying advanced chronic renal failure. BMJ 3:352-353 
